Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2007Open Access

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCarlo SalvaraniUniversity of SienaPMPierluigi MacchioniAzienda Sanitaria Unità Locale di Reggio EmiliaCMCarlo Umberto Manzini

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salvarani et al. (2007) studied this question.

synapsesocial.com/papers/6a7d3aca86b21ee5f583d6c8https://doi.org/10.7326/0003-4819-146-9-200705010-00005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis1988 · 19,985 citations
  2. 2Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis - A prospective two-year study in 273 patients2001 · 80 citations
  3. 3A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis2002 · 150 citations
  4. 4Long‐term Corticosteroid Treatment in Giant Cell Arteritis1986 · 119 citations
  5. 5Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone2001 · 516 citations